PUBLISHER: Allied Market Research | PRODUCT CODE: 1239513
PUBLISHER: Allied Market Research | PRODUCT CODE: 1239513
The Tissue Expanders Market valued for $671.5 million in 2021 and is estimated to reach $1,180.0 million by 2031, exhibiting a CAGR of 5.8% from 2022 to 2031. Tissue expanders are balloons made of silicon and filler ingredients, molded into a pre-shaped prosthesis, which can be filled with saline through a valve system, which is either incorporated on the expander's surface (early expanders had this structure which is not seen nowadays) or is remote and connected by a flexible silastic filling tube to the expander (nearly all expanders nowadays have a remote valve). The main benefit of the remote valve and filling tube is that it keeps the injection point far from the balloon, eliminating any potential hazards of balloon puncture during expander inflation. Remote positioning enables placing at a location beneath the skin where it can be felt readily.
The growth of tissue expanders market is driven by technological advancement for development of different tissue expanders and rise in the prevalence of breast cancer. In addition, increase in number of various strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. Breast cancer is the most common type of cancer in women and it necessitates mastectomy to remove malignant cells, resulting in an increase in the use of extremity tissue expanders for breast reconstruction. Thus, rise in number of female patients suffering from breast cancer is anticipated to drive the demand for tissue expanders and fuel the market growth.
Rise in the adoption of minimally invasive procedure for improvement of aesthetic appearance is expected to drive the demand for tissue expanders and boost the market growth. For instance, according to the International Society of Aesthetic Plastic Surgery, in 2020, it was reported that, approximately 10,129,528 cosmetic procedures were performed by plastic surgeons worldwide. Tissue expanders are used for scalp reconstruction, breast reconstruction, oral & maxillofacial reconstruction, and to repair burn scars. Thus, rise in number of burn injuries and oral & maxillofacial deformity lead to upsurge in demand for tissue expanders.
In addition, the Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, & security of human & veterinary drugs, biological products, and medical devices. Rise in product approval for tissue expanders by Food and Drug Administration (FDA) is anticipated to drive the growth of tissue expanders market. For instance, in October 2022, according to Food and Drug Administration, it was reported that, the FDA has cleared 48 tissue expanders and accessories.
In addition, rise in expenditure by governments to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals and clinics. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for tissue expanders for reconstructive procedures, thereby boosting the market growth.
On the other hand, high cost of treatment and side effects of the tissue expansion procedures are some factors that are anticipated to restrain the growth of the tissue expanders market.
The tissue expanders market is segmented on the basis of lesion site, product shape, application, end user, and region. By product type, the market is fragmented into lower extremity, upper extremity, and others. The others segment is further divided into trunk, back, and head. By product shape, the market is categorized into rectangular, crescent, round, and others. The others segment is further divided into anatomical, elliptical, and cylindrical. On the basis of application, the market is classified into breast reconstruction, facial reconstruction, and others. The others segment is further divided into congenital disorders, burn scar, and scalp reconstruction. By end user, the market is fragmented into hospitals, cosmetic clinics, and others. The others segment is further bifurcated into ambulatory surgical centers and burn center. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global tissue expanders market include: GC aesthetic PLC, Abbvie Inc, Guangzhou Wanhe Plastic Materials Co. Ltd., Johnson & Johnson, Groupe Sebbin SAS, Sientra, Inc., pmt corporation, POLYTECH Health & Aesthetics Establishment Labs, and Silimed.